Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment
Yazarlar (3)
Serap Yalçın
Kırşehir Ahi Evran Üniversitesi, Türkiye
Kırşehir Ahi Evran Üniversitesi, Türkiye
Seda Yalçınkaya
Süleyman Demirel Üniversitesi, Türkiye
Süleyman Demirel Üniversitesi, Türkiye
Prof. Dr. Fahriye ERCAN Kırşehir Ahi Evran Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(Uluslararası alan indekslerindeki dergilerde yayınlanan tam makale)
|
||
| Dergi Adı | Current Pharmacology Reports | ||
| Dergi ISSN | 2198-641X Scopus Dergi | ||
| Dergi Tarandığı Indeksler | Chemical Abstracts Service (CAS) | ||
| Makale Dili | İngilizce | Basım Tarihi | 02-2021 |
| Cilt / Sayı / Sayfa | 7 / 2 / 42–48 | DOI | 10.1007/s40495-021-00254-9 |
| Makale Linki | https://link.springer.com/content/pdf/10.1007/s40495-021-00254-9.pdf | ||
| Özet |
| The novel human coronavirus was firstly emerged in December 2019 in Wuhan, China, and has spread rapidly around the world. There is no known specific effective treatment of COVID-19. The most commonly used agents against this disease both in Turkey and around the world include chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir, and remdesivir. In the study, we investigated the drug potential of molecules that the components of an important medicinal plant Hypericum perforatum by using molecular docking and drug possibility properties of these molecules. The molecular docking results showed that the most stable complex was obtained with COVID-19 main protease and hypericin/isohypericin ligands with − 11 kcal/mol binding energy. Furthermore, ADMET, drug-likeness features of compounds of H. perforatum were investigated using the rules of Lipinski, Veber, and Ghose. According to … |
| Anahtar Kelimeler |
| ADMET | COVID-19 | Drug-likeness drug | Hypericum perforatum | Molecular docking |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| SCOPUS | 20 |
| Google Scholar | 33 |